2060-5587

Journal of Psychedelic Studies

Akademiai Kiado Zrt.

View prefix report (10.1556)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 269 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact269 DOIs
2

Add abstracts to 266 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact266 DOIs
3

Add license metadata to 266 records

License metadata tells indexers and readers how each article may be reused.

High impact266 DOIs

DOIs for this ISSN

Showing the top 5 of 274 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The influence of therapists’ first-hand experience with psyc… (10.1556/2054.2018.009)
Abstract ORCID License
141.91 77
2 Subjective effectiveness of ibogaine treatment for problemat… (10.1556/2054.01.2017.009)
Abstract ORCID License
128.70 51
3 A phenomenological analysis of the subjective experience eli… (10.1556/2054.01.2017.007)
Abstract ORCID License
116.72 35
4 An ontology of psychedelic entity experiences in evolutionar… (10.1556/2054.2018.002)
Abstract ORCID License
112.89 31
5 The antiaddictive effects of ibogaine: A systematic literatu… (10.1556/2054.01.2016.001)
Abstract ORCID License
109.68 28
6 Inside bad trips: Exploring extra-pharmacological factors (10.1556/2054.2018.001)
Abstract ORCID License
104.85 24
7 Mental health of a self-selected sample of psychedelic users… (10.1556/2054.2018.006)
Abstract ORCID License
102.13 22
8 Treating drug dependence with the aid of ibogaine: A qualita… (10.1556/2054.01.2016.002)
Abstract ORCID License
100.68 21
9 Perceptions of the medicinal value of hallucinogenic drugs a… (10.1556/2054.01.2017.008)
Abstract ORCID License
95.91 18
10 The hyperassociative mind: The psychedelic experience and Me… (10.1556/2054.01.2017.006)
Abstract ORCID License
85.96 13
11 A phenomenological investigation into the lived experience o… (10.1556/2054.2018.004)
Abstract ORCID License
85.96 13
12 “Ayahuasca turned on my mind’s eye”: Enhanced visual imagery… (10.1556/2054.2018.008)
Abstract ORCID License
85.96 13
13 Detoxification from methadone using low, repeated, and incre… (10.1556/2054.01.2017.005)
Abstract ORCID License
83.55 12
14 Long-lasting analgesic effect of the psychedelic drug <i>cha… (10.1556/2054.2019.001)
Abstract ORCID License
83.55 12
15 The psychedelic religion of mystical consciousnessReviews (10.1556/2054.2018.003)
Abstract ORCID License
75.00 9
16 Motivational structure of ayahuasca drinkers in social netwo… (10.1556/2054.2018.010)
Abstract ORCID License
75.00 9
17 Internet method for the extraction of <i>N,N</i>-dimethyltry… (10.1556/2054.2019.009)
Abstract ORCID License
71.57 8
18 Anxiety, panic, and hopelessness during and after ritual aya… (10.1556/2054.01.2017.004)
Abstract ORCID License
63.38 6
19 Psychedelic therapy in the Czech Republic: A theoretical con… (10.1556/2054.2019.003)
Abstract ORCID License
63.38 6
20 The psychedelic renaissance and the limitations of a White-d… (10.1556/2054.2019.015)
ORCID
56.32 178
21 Making psychedelics into medicines: The politics and paradox… (10.1556/2054.2019.018)
ORCID
48.11 83
22 The oldest archeological data evidencing the relationship of… (10.1556/2054.2019.008)
ORCID
47.85 81
23 The role of Indigenous knowledges in psychedelic science (10.1556/2054.2019.031)
ORCID
46.73 73
24 Diversity, equity, and access in psychedelic medicine (10.1556/2054.2019.032)
ORCID
45.65 66
25 Culturally informed research design issues in a study for MD… (10.1556/2054.2019.016)
ORCID
44.63 60
26 Use of psilocybin (“mushrooms”) among US adults: 2015–2018 (10.1556/2054.2020.00159)
ORCID
43.51 54
27 Race as a component of set and setting: How experiences of r… (10.1556/2054.2019.022)
ORCID
41.80 46
28 Introduction: Evidence for entheogen use in prehistory and w… (10.1556/2054.2019.024)
ORCID
40.58 41
29 A phenomenology of subjectively relevant experiences induced… (10.1556/2054.2019.007)
ORCID
37.96 32
30 Psychedelics and potential benefits in “healthy normals”: A… (10.1556/2054.2019.029)
ORCID
37.96 32
31 Caught in the crossfire: Plant medicines and the Psychoactiv… (10.1556/2054.01.2017.010)
Abstract ORCID License
35.78 2
32 The dissociative psychedelic renaissance (10.1556/2054.2018.013)
Abstract ORCID License
35.78 2
33 Reply to “Ayahuasca turned on my mind’s eye”: A case of acqu… (10.1556/2054.2018.014)
Abstract ORCID License
35.78 2
34 Psychedelic-assisted therapy for anxiety and depression in t… (10.1556/2054.2019.005)
Abstract ORCID License
35.78 2
35 Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context… (10.1556/2054.2019.033)
ORCID
33.56 21
36 Peak-experience and the entheogenic use of cannabis in world… (10.1556/2054.2020.00122)
ORCID
32.53 19
37 Reflections on crafting an ayahuasca community guide for the… (10.1556/2054.2020.00124)
ORCID
32.53 19
38 “Go ask Alice, when she’s 10-feet tall”: Psychosocial correl… (10.1556/2054.2019.014)
ORCID
31.38 17
39 EDITORIAL (10.1556/2054.2019.021)
Abstract ORCID
30.10 3
40 Intersectional insights from an MDMA-assisted psychotherapy… (10.1556/2054.2019.017)
ORCID
28.65 13
41 Psilocybin for depression: Considerations for clinical trial… (10.1556/2054.2019.026)
ORCID
28.65 13
42 Novel treatment of opioid use disorder using ibogaine and ib… (10.1556/2054.2020.00133)
ORCID
25.00 9
43 Entheogens in Buddhism (10.1556/2054.2020.00161)
Abstract ORCID
23.86 2
44 On microdosing with the Mario mushroom (10.1556/2054.2023.00303)
Abstract References
23.86 2
45 Psychedelics and the media in the Visegrad countries (10.1556/2054.2018.007)
Abstract ORCID License
22.58 1
46 Intercultural, intermolecular: An ethnobotanical examination… (10.1556/2054.2019.002)
Abstract ORCID License
22.58 1
47 Getting high with the most high: Entheogens in the Old Testa… (10.1556/2054.2019.004)
ORCID
21.13 6
48 Soma and Haoma: Ayahuasca analogues from the Late Bronze Age (10.1556/2054.2019.013)
ORCID
21.13 6
49 The influence of context on ayahuasca experiences: An analys… (10.1556/2054.2019.028)
ORCID
21.13 6
50 Psilocybin use patterns and perception of risk among a cohor… (10.1556/2054.2022.00214)
ORCID
21.13 6